Medcan will facilitate: • the import and export of products under CGB’s arrangements with third parties (including CannTab Therapeutics Ltd (CannTab)) and Pharmocann Ltd (Pharmocann)) as well as any future products that CGB may want to manufacture or distribute; • the manufacture of CGB’s products (using either its own facility or the facility of third parties); •
The storage of and growing of CGB’s unique genetics and seed bank; and • use of a designated area within its facility for a lab for genetic development for CGB, and for manufacturing of oil extraction for CGB
Great question Smoex!
Not sure if the above highlighted in bold applies to your question or if that is on a much smaller basis?
I wonder if the end game still involves Medcan growing for us on scale?
Perhaps if revenue is strong a deal to fit-out Medcan facility can still be struck in the not too distant future?
Perhaps CGL share price will soar & Medcan will take some profits for the fit-out?
All very interesting.
I hope your getting your rest
@Neil1959 ...Your going to need it over the coming days/weeks/months.
